Early life exposure to inorganic fluoride has been associated with adverse cognitive, renal and metabolic outcomes in children. However, scarce evidence exists linking fluoride exposure and echocardiographic parameters. A cross-sectional study, involving 374 children, was conducted in Chihuahua, Mexico. We assessed associations between urinary fluoride levels and dental fluorosis and echocardiographic parameters using multivariate linear regression models. The mean (total range) of fluoride concentrations in drinking water were 0.95 (0.01-5.84) mg/L, and urinary fluoride adjusted for specific gravity was 2.51 (0.67-6.75) μg/mL. Of the children, 38.0 % had dental fluorosis and 36.6 % were exposed to fluoride levels in drinking water above the WHO's limit of 1.5 mg/L. The median (interquartile range) for left ventricular mass (LVM) was 73.58 (59.84-86.5) g. Fifty-nine percent of children had normal LV geometry pattern and 35.3 % had LV concentric remodeling. Urinary fluoride (third vs. first tertile) was associated with increased LVM (3.97 g; 95 % CI: 0.60-7.34 g; p = 0.021) and cardiac output (0.26 L/min; 95 % CI: 0.042-0.48 L/min; p = 0.019) in models adjusted for potential confounders. Cardiac output, ejection fraction (EF) and shortening fraction (SF) were positively and significantly associated with dental fluorosis (vs. no dental fluorosis) [(0.21 L/min; 95 % CI: 0.034-0.39 L/min; p = 0.020); (2.01 %; 95 %CI: 0.58-3.45 %; p = 0.006); (1.77 %; 95 % CI: 0.57-2.96 %; p = 0.004), respectively]. We found sex-specific associations for dental fluorosis and LVM increase with statistically significant associations in girls but not in boys (p-interaction = 0.018). Our findings showed that high fluoride exposure in early life is associated with structural and functional cardiac parameters in children environmentally exposed to this contaminant.
Background: Antibiotic drug resistance is a serious global health problem that threatens therapeutics against infectious diseases. As antibiotics become less effective every year, our objective was to evaluate the adjuvant activity of methanolic extracts of Moringa oleifera seed combined with antibiotics of clinical use against multidrug-resistant Escherichia coli isolated from street food samples searching for a new alternative to treat infectious diseases commonly treated with antibiotics. Methods: Secondary metabolites of M. oleifera seeds were obtained through maceration (methanol 80%) and detected following qualitative phytochemical assays. MIC, MBC and tolerance level were determined using microdilution tests. Antimicrobial activity was tested by sensitivity analysis, and the adjuvant activity was explored in combination with twelve antibiotics against the E. coli samples. Results: Alkaloids, phenolic compounds, flavonoids, and polyphenols were detected. MIC and MBC values ranged from 31.3 to 62 mg/mL and 62–125 mg/mL, respectively. The extract showed low antimicrobial activity against the multidrug-resistant E. coli, but the inhibitory capacity of ampicillin, cephalexin, and amoxicillin/clavulanic acid was significantly increased when combined with the plant extract. In contrast, the activity of ciprofloxacin, levofloxacin, tetracycline, polymyxin, and nalidixic acid decreased with the extract. Conclusion: Methanolic extracts of M. oleifera seeds represent a potential adjuvant for beta-lactams in the face of the growing problem of global antimicrobial resistance. This study represents the first steps in exploring the adjuvant capacity of plants against resistant environmental pathogens in Mexico.
The major histocompatibility complex (MHC) plays a crucial role in immune responses and is associated with disease susceptibility. This study systematically reviews MHC class I and class II allele frequencies and their associations with diseases in the Mexican population from 1979 to 2023. A systematic review following PRISMA guidelines was conducted. Reports were obtained from the Allele Frequency Net Database and PubMed using keywords related to HLA and Mexican populations. A total of 776 reports were screened, and 214 were retained for final analysis. Seventy-six studies comprising allele frequency data from over 20,000 individuals across Mexican states and indigenous communities were analyzed. In addition, over 138 articles were examined to identify alleles associated with various diseases. The analysis identified 117 alleles whose frequencies varied regionally within Mexico. While DPA1*01, DPB1*04:01, and DQA1*03 were predominant, DRB1*04, DQB1*03, and DQA1*05 were also prominent but variable. Certain alleles, such as A*02, B*35, C*04, and C*07, were relatively common in the population. Numerous disease correlations were uncovered, such as B*27's strong association with spondyloarthropathies. DRB1*15:01 and DRB1*04 conferred an increase in multiple sclerosis, while DRB1*04 may protect against some skin diseases. This review improves the understanding of MHC allele frequencies and disease associations in Mexicans, highlighting genetic diversity. The findings lay the groundwork for future research on genetic predispositions and health outcomes, aiding healthcare strategies in this diverse population. Further studies are needed to address data gaps and refine genetic profiles for targeted medical applications.